Provexis plc (AIM:PXS)
London · Delayed Price · Currency is GBP · Price in GBX 1.010
-0.040 (-3.81%)
Jan 23, 2026, 3:07 PM GMT
Provexis Revenue
Provexis had revenue of 364.37K GBP in the half year ending September 30, 2025, a decrease of -5.98%. This brings the company's revenue in the last twelve months to 871.27K, down -27.38% year-over-year. In the fiscal year ending March 31, 2025, Provexis had annual revenue of 1.29M with 61.13% growth.
Revenue (ttm)
871.27K
Revenue Growth
-27.38%
P/S Ratio
26.98
Revenue / Employee
435.63K
Employees
2
Market Cap
23.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.29M | 490.28K | 61.13% |
| Mar 31, 2024 | 801.96K | 412.05K | 105.68% |
| Mar 31, 2023 | 389.92K | -36.25K | -8.51% |
| Mar 31, 2022 | 426.17K | -79.16K | -15.67% |
| Mar 31, 2021 | 505.33K | 157.39K | 45.24% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Haleon | 11.02B |
| Hikma Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 439.54M |
| ECO Animal Health Group | 85.81M |
| Animalcare Group | 81.07M |
| Animalcare Group | 81.07M |
| Allergy Therapeutics | 55.04M |
| Venture Life Group | 31.23M |
Provexis News
- 2 months ago - AIM Market Roundup: Provexis, Geo Exploration, Sabien - The Armchair Trader